Your session is about to expire
← Back to Search
Intraocular Lens
AcrySof IQ Vivity Extended Vision IOL and AcrySof IQ Vivity Toric Extended Vision IOL for Aphakia
N/A
Waitlist Available
Research Sponsored by Alcon Research
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
* 22 years old or older at Visit 1.
* Able to understand and sign an approved informed consent form.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up visit 1, year 3-5 postoperative
Awards & highlights
Summary
The purpose of this post-market study is to describe the long-term safety and performance of AcrySof IQ Vivity and AcrySof IQ Vivity Toric intraocular lens (IOL) models in a real-world setting through routine clinical practice.
Who is the study for?
This trial is for individuals who have had their natural lens removed (aphakia), struggle with near vision due to aging (presbyopia), or have blurred vision caused by an irregularly shaped cornea (astigmatism).
What is being tested?
The study is evaluating the long-term safety and effectiveness of AcrySof IQ Vivity Extended Vision IOLs, which are artificial lenses implanted in the eye to improve vision after cataract surgery.
What are the potential side effects?
While specific side effects are not listed here, common side effects of intraocular lens implantation can include visual disturbances like glare and halos, mild discomfort, redness, and risk of infection.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ visit 1, year 3-5 postoperative
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~visit 1, year 3-5 postoperative
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Incidence of adverse events
Incidence of device deficiencies
Mean Binocular Best Corrected Distance Visual Acuity (BCDVA) at Visit 1
Trial Design
1Treatment groups
Experimental Treatment
Group I: AcrySof IQ Vivity Extended Vision IOL and AcrySof IQ Vivity Toric Extended Vision IOLExperimental Treatment1 Intervention
AcrySof IQ Vivity Extended Vision IOL implanted in both eyes during cataract surgery
Find a Location
Who is running the clinical trial?
Alcon ResearchLead Sponsor
719 Previous Clinical Trials
126,254 Total Patients Enrolled
19 Trials studying Aphakia
6,035 Patients Enrolled for Aphakia
Clinical Trial Management Operations, SurgicalStudy DirectorAlcon Research, LLC
1 Previous Clinical Trials
100 Total Patients Enrolled
1 Trials studying Aphakia
100 Patients Enrolled for Aphakia
Share this study with friends
Copy Link
Messenger